comparemela.com
Home
Live Updates
JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS) : comparemela.com
JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)
Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizures in LGS...
Related Keywords
Australia ,
Japan ,
United States ,
Belgium ,
Smyrna ,
Izmir ,
Turkey ,
Colorado ,
France ,
Brussels ,
Bruxelles Capitale ,
America ,
French ,
Erica Puntel ,
Nick Francis ,
Kelly Knupp ,
Antje Witte ,
Laurent Schots ,
Twitter ,
Ucb Inc ,
Drug Administration ,
Zogenix Inc ,
Program See Boxed Warning ,
Group Of Companies ,
Zogenix Press ,
Major Concerns ,
Corporate Communications ,
European Medicines Agency ,
Source Ucb Inc ,
Euronext ,
Associate Professor ,
Hospital Colorado ,
Principal Investigator ,
North America ,
Prescribing Information ,
Boxed Warning ,
Heart Disease ,
Pulmonary Arterial Hypertension ,
Mitigation Strategy ,
Decreased Weight ,
Antiepileptic Drugs ,
Blood Pressure ,
Euronext Brussels ,
Seizures Associated ,
Lennox Gastaut Syndrome ,
Randomized Clinical ,
Treatment Landscape ,
Gastaut Syndrome ,
Zogenix Submits New Drug Application ,
Epileptic Seizures Associated ,
Ucb ,
Nc ,
comparemela.com © 2020. All Rights Reserved.